TP53 and type 2 diabetes mellitus: Target gene prediction analysis revealed that these miRNAs play a role in altering the expression of genes involved in regulation of complex cardio‐metabolic diseases, as evidenced by their involvement in pathways such as insulin signaling, T2DM, p53, and cancer signaling.